CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 81 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-01 | Bilbo Patrick Chief Operating Officer | Shares withheld for taxes | −2,497 | $19.83 | $50K | 164,120 |
| 2021-04-01 | Freedman Lori VP and General Counsel | Shares withheld for taxes | −1,975 | $19.83 | $39K | 33,751 |
| 2021-04-01 | Gillheeney Gary S. President and CEO | Shares withheld for taxes | −6,265 | $19.83 | $124K | 133,542 |
| 2021-04-01 | Montecalvo Antonio S. VP Health Policy & Contracting | Shares withheld for taxes | −1,770 | $19.83 | $35K | 69,556 |
| 2021-03-01 | Wisdom Starr 10% owner | Sale | −8,050 | $16.50 | $133K | 40,000 |
| 2021-02-25 | Wisdom Starr 10% owner | Sale | −27,385 | $14.71 | $403K | 50,000 |
| 2021-02-25 | Wisdom Starr 10% owner | Sale | −1,950 | $16.50 | $32K | 48,050 |
| 2021-02-24 | Wisdom Starr 10% owner | Sale | −15,154 | $14.70 | $223K | 77,385 |
| 2021-02-18 | Gillheeney Gary S. President and CEO | Sale | −16,663 | $12.85 | $214K | 139,807 |
| 2021-02-17 | Gillheeney Gary S. President and CEO | Sale | −78,201 | $13.30 | $1.0M | 167,644 |
| 2021-02-17 | Gillheeney Gary S. President and CEO | Sale | −11,174 | $13.82 | $154K | 156,470 |
| 2021-02-16 | Wisdom Starr 10% owner | Sale | −170,000 | $12.95 | $2.2M | 92,539 |
| 2021-02-16 | Francisco David Chief Financial Officer | Grant or award | +10,965 | 16,361 | ||
| 2021-02-16 | Francisco David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +83,955 | 83,955 | ||
| 2021-02-16 | Montecalvo Antonio S. VP Health Policy & Contracting | Grant or award | +8,260 | 71,326 | ||
| 2021-02-16 | Montecalvo Antonio S. VP Health Policy & Contracting | Grant or award · Stock Option (Right to Buy) | +63,246 | 63,246 | ||
| 2021-02-16 | Grow Brian Chief Commercial Officer | Grant or award | +10,782 | 46,549 | ||
| 2021-02-16 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +82,556 | 82,556 | ||
| 2021-02-16 | Freedman Lori VP and General Counsel | Grant or award | +8,808 | 35,726 | ||
| 2021-02-16 | Freedman Lori VP and General Counsel | Grant or award · Stock Option (Right to Buy) | +67,444 | 67,444 |
Page 23 of 24 · 473 trades